Document Classification

Section Type: RESULTS

Text: Regardless of low - or high-dose aspirin use, prasugrel had lower rates of the primary efficacy endpoint (cardiovascular death, myocardial infarction, or stroke [CVD/MI/stroke]) (hazard ratio [HR] CVD/MI/stroke = 0. 78 [95 % confidence interval (CI) 0. 64 to 0. 95] and HRCVD/MI/stroke = 0. 87 [95 % CI 0. 69 to 1. 10], respectively ; p value for interaction = 0. 48) and higher rates of the primary safety endpoint (HR TIMI major bleeding = 1. 40 [95 % CI 0. 81 to 2. 42] and TIMImajor bleeding = 1. 30 [95 % CI 0. 63 to 2. 68], respectively ; p value for interaction = 0. 84) compared with clopidogrel.